GPRC5D and Miyoshi myopathy: Although around 45% of MM cells harbored a nonsense mutation (p.Arg233Ter), a missense mutation in GPRC5D (p.Tyr257Ser) with a cancer cell fraction (CCF) of 28% represented another subclone because both mutations were mutually exclusive after phasing the reads.